St-Basile-le-Grand, Canada

Deborah Anne Nicoll-Griffith

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Deborah Anne Nicoll-Griffith

Introduction

Deborah Anne Nicoll-Griffith is a notable inventor based in St-Basile-le-Grand, CA. She has made significant contributions to the field of medical research, particularly in the treatment and prophylaxis of HIV and AIDS. With a total of three patents to her name, her work has the potential to impact countless lives.

Latest Patents

Her latest patents focus on methods for the treatment and prophylaxis of HIV and AIDS. The inventions are directed towards the inhibition of HIV reverse transcriptase, which is crucial for the treatment of HIV infections. These methods involve administering a compound of structural Formula I or a pharmaceutically acceptable salt or co-crystal thereof, wherein X is either —F or —Cl, less frequently than once daily. This innovative approach aims to delay the onset or progression of AIDS or ARC.

Career Highlights

Deborah is currently associated with Merck Sharp & Dohme Corporation, where she continues her research and development efforts. Her work is recognized for its potential to change the landscape of HIV treatment and prevention.

Collaborations

Some of her notable coworkers include Daria Hazuda and Michael D Miller, who contribute to the collaborative efforts in advancing research in this critical area.

Conclusion

Deborah Anne Nicoll-Griffith's contributions to the field of HIV and AIDS treatment exemplify the impact of innovative research in medicine. Her patents reflect a commitment to improving health outcomes for individuals affected by these diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…